Nantahala Capital Management, LLC Amryt Pharma PLC Transaction History

Nantahala Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.0 - $14.77 $4.32 Million - $9.11 Million	-616,633 Reduced 42.9%	820,825 $12 Million
Q3 2022 Nov 10, 2022	SELL	$6.8 - $8.01 $850,000 - $1 Million	-125,000 Reduced 8.0%	1,437,458 $9.95 Million
Q2 2022 Aug 15, 2022	BUY	$6.85 - $8.87 $3.36 Million - $4.35 Million	490,922 Added 45.81%	1,562,458 $10.9 Million
Q1 2022 May 13, 2022	BUY	$6.3 - $10.86 $6.75 Million - $11.6 Million	1,071,536 New	1,071,536 $8.86 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.